[go: up one dir, main page]

MX2016003791A - Composiciones y método para desestabilizar, alterar y dispersar biopelículas. - Google Patents

Composiciones y método para desestabilizar, alterar y dispersar biopelículas.

Info

Publication number
MX2016003791A
MX2016003791A MX2016003791A MX2016003791A MX2016003791A MX 2016003791 A MX2016003791 A MX 2016003791A MX 2016003791 A MX2016003791 A MX 2016003791A MX 2016003791 A MX2016003791 A MX 2016003791A MX 2016003791 A MX2016003791 A MX 2016003791A
Authority
MX
Mexico
Prior art keywords
biofilms
altering
compositions
destabilizing
removal
Prior art date
Application number
MX2016003791A
Other languages
English (en)
Other versions
MX374836B (es
Inventor
Du-Thumm Laurence
Rickard Alexander
Underwood Adam
Original Assignee
Univ Michigan Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52744423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016003791(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan Regents filed Critical Univ Michigan Regents
Publication of MX2016003791A publication Critical patent/MX2016003791A/es
Publication of MX374836B publication Critical patent/MX374836B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Birds (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)

Abstract

La presente descripción se relaciona con composiciones y métodos para desestabilizar biopelículas, alterar la estructura 3D de biopelículas y dispersar biopelículas, para mejorar la remoción de células de la biopelícula y/o sensibilidad a otros agentes (por ejemplo, tratamientos ambientales y aplicados concurrentemente) En particular, la presente descripción se relaciona con el uso de L-arginina en la remoción y/o sensibilización (por ejemplo, a antimicrobianos) de microorganismos en aplicaciones médicas, industriales, domésticas o ambientales, así como el tratamiento de infecciones bacterianas (por ejemplo, en biopelículas).
MX2016003791A 2013-09-24 2014-09-24 Plásmido para monitorizar arginina o ai-2 en biopelículas. MX374836B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361881762P 2013-09-24 2013-09-24
US201461972920P 2014-03-31 2014-03-31
PCT/US2014/057235 WO2015048146A1 (en) 2013-09-24 2014-09-24 Compositions and method for destabilizing, altering, and dispersing biofilms

Publications (2)

Publication Number Publication Date
MX2016003791A true MX2016003791A (es) 2017-01-20
MX374836B MX374836B (es) 2025-03-06

Family

ID=52744423

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003791A MX374836B (es) 2013-09-24 2014-09-24 Plásmido para monitorizar arginina o ai-2 en biopelículas.

Country Status (11)

Country Link
US (2) US20160235698A1 (es)
EP (3) EP3049073B1 (es)
CN (3) CN115177607A (es)
AU (6) AU2014326756B2 (es)
BR (1) BR112016006584B1 (es)
DK (1) DK3049073T3 (es)
ES (1) ES2847388T3 (es)
MX (1) MX374836B (es)
PL (1) PL3049073T3 (es)
WO (1) WO2015048146A1 (es)
ZA (1) ZA201602797B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
WO2015048146A1 (en) 2013-09-24 2015-04-02 The Regents Of The University Of Michigan Compositions and method for destabilizing, altering, and dispersing biofilms
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
US12194105B2 (en) * 2018-02-21 2025-01-14 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for new antimicrobial agents with secondary mode of action provided by conjugation of an antimicrobial to a guanidinium-rich molecular transporter
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US10927397B2 (en) 2018-10-16 2021-02-23 Sterilex, Llc Compositions, devices and methods for detecting biofilms
CA3123091A1 (en) * 2018-12-26 2020-07-02 Colgate-Palmolive Company Methods of shifting biofilm in the oral cavity from pathogenic to healthy biofilm
CN113271918A (zh) * 2018-12-26 2021-08-17 高露洁-棕榄公司 使用精氨酸降低病原性细菌
US20210196598A1 (en) * 2018-12-26 2021-07-01 Colgate-Palmolive Company Specific Co-Aggregation Inhibition by Arginine
AU2020253232B2 (en) * 2019-03-29 2022-12-08 Colgate-Palmolive Company Oral care product
CN110583697B (zh) * 2019-09-20 2021-04-06 浙江工商大学 去除铜绿假单胞菌生物膜用的高效化学生物制剂及其应用
US12332160B2 (en) 2019-11-08 2025-06-17 Colgate-Palmolive Company Apparatus, system, and method for testing biological samples
WO2021092613A1 (en) * 2019-11-08 2021-05-14 Colgate-Palmolive Company Methods of modifying biofilm
CN111299267B (zh) * 2020-02-12 2021-10-22 上海交通大学 一种基于群感效应的供水管网生物膜控制方法及其应用
WO2023114550A2 (en) * 2021-12-19 2023-06-22 The Trustees Of Columbia University In The City Of New York Engineering bacteria swarm patterns for spatiotemporal information encoding
CN119112857A (zh) * 2024-09-18 2024-12-13 中国科学技术大学 抑制金葡菌生物被膜形成的组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539234A (en) 1981-05-27 1985-09-03 Unitika Ltd. Urethral catheter capable of preventing urinary tract infection and process for producing the same
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
WO2000066616A1 (en) * 1999-05-03 2000-11-09 Advanced Research & Technology Institute, Inc. METHODS AND COMPOSITIONS FOR CONTROLLING DENTAL CARIES, AND RECOMBINANT SmaA POLYPEPTIDES USEFUL FOR SAME
AU2001286741A1 (en) * 2000-08-25 2002-03-04 Trustees Of Tufts College Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms
US20100021942A1 (en) * 2008-07-25 2010-01-28 Paul Freemont Cell-free expression system for the detection of bacterial biofilms
ES2385236B8 (es) * 2008-12-22 2014-01-31 Micropure Inc. Composición y método para reducir la desmineralización de los dientes.
BR112012030037B1 (pt) * 2010-06-23 2017-06-27 Colgate-Palmolive Company Oral hygiene composition, use and article
CA2816241C (en) 2010-10-27 2016-04-19 Colgate-Palmolive Company Oral care composition comprising arginine and calcium carbonate
US9717929B2 (en) * 2010-12-07 2017-08-01 Colgate-Palmolive Company Dentifrice compositions containing calcium silicate and a basic amino acid
CA2853857C (en) * 2011-10-31 2022-06-14 Kane Biotech Inc. Compositions and methods for preventing and treating oral diseases
RU2014128847A (ru) * 2011-12-15 2016-02-10 Колгейт-Палмолив Компани Композиции для гигиены полости рта
WO2015048146A1 (en) 2013-09-24 2015-04-02 The Regents Of The University Of Michigan Compositions and method for destabilizing, altering, and dispersing biofilms

Also Published As

Publication number Publication date
DK3049073T3 (da) 2021-02-01
BR112016006584B1 (pt) 2022-11-29
AU2024264692A1 (en) 2024-12-05
AU2016202002A1 (en) 2016-04-21
EP3049073A1 (en) 2016-08-03
AU2021202650B2 (en) 2022-09-08
US10570401B2 (en) 2020-02-25
MX374836B (es) 2025-03-06
AU2019271937A1 (en) 2019-12-19
EP3049073A4 (en) 2017-03-15
EP3150715A1 (en) 2017-04-05
AU2014326756A1 (en) 2016-04-07
US20160235698A1 (en) 2016-08-18
BR112016006584A2 (pt) 2017-08-01
AU2019271937B2 (en) 2021-01-28
US20160304886A1 (en) 2016-10-20
AU2021202650A1 (en) 2021-05-27
AU2014326756B2 (en) 2019-08-29
EP3831374A1 (en) 2021-06-09
CN106029062A (zh) 2016-10-12
EP3049073B1 (en) 2020-11-04
AU2022271381B2 (en) 2024-08-15
CN115177607A (zh) 2022-10-14
CN110129352A (zh) 2019-08-16
ZA201602797B (en) 2018-12-19
WO2015048146A1 (en) 2015-04-02
AU2022271381A1 (en) 2022-12-15
EP3150715B1 (en) 2018-11-14
ES2847388T3 (es) 2021-08-03
AU2016202002B2 (en) 2017-10-12
PL3049073T3 (pl) 2021-10-25

Similar Documents

Publication Publication Date Title
MX2016003791A (es) Composiciones y método para desestabilizar, alterar y dispersar biopelículas.
PH12016500207A1 (en) Anti-infective compounds
MX2016009898A (es) Tratamientos para acne resistente.
BR112017028318A2 (pt) compostos antibacterianos
CL2015003120A1 (es) Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biológico que las contienen
BR112016007572A2 (pt) di-hidroxialquil substituído por poligalactomanano, e métodos para produzir e usar o mesmo
UY35510A (es) ?composiciones y métodos para mejorar la estabilidad microbiana?.
BR112012018021A2 (pt) antídotos anticoagulantes.
MX2015000995A (es) Formulaciones desinfectantes topicas y uso de las mismas.
EP3912986A3 (en) Crp capture/detection of bacteria
CO6771428A2 (es) Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales
MX390762B (es) Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas
BR112012017473A2 (pt) pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos
CO6761338A2 (es) Derivados de fluoro-piridinona utiles como agentes antibacterianos
BR112015023648A2 (pt) revestimento de superfície reativo com propriedades de descontaminação química e biocidas
CL2015003019A1 (es) Derivados biaromáticos antibacterianos
DOP2015000223A (es) Composiciones antimicrobianas y métodos de uso relacionados
UA109557C2 (uk) Похідні 2-піперазин-1-іл-4h-1,3-бензотіазин-4-ону та їх застосування для лікування інфекцій у ссавців
BR112015018547A2 (pt) microbiocidas
MX2019006620A (es) Composiciones de polisacaridos y metodos de uso.
BR112016005417A8 (pt) "compostos derivados de desoxinojirimicina, composição farmacêutica e seus usos"
BR112015004178A2 (pt) gluconato de clorexidina solubilizado em um monoacilglicerídeo hidrofóbico
BR112015026193B8 (pt) Composição farmacêutica, método para formular uma composição farmacêutica, uso da composição farmacêutica, método para inibir a formação de biofilme em uma superfície, e, artigo fabricado para curativo
BR112014016803A2 (pt) amidas macrocíclicas como inibidoras de protease
WO2013166282A3 (en) Methods and compositions for treating bacterial infection

Legal Events

Date Code Title Description
FG Grant or registration